Effect of rituximab on human in vivo antibody immune responses-Reference-Cited by-同舟云学术

Effect of rituximab on human in vivo antibody immune responses

Published:2011-12 Issue:6 Volume:128 Page:1295-1302.e5
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Pescovitz Mark D.,Torgerson Troy R.,Ochs Hans D.,Ocheltree Elizabeth,McGee Paula,Krause-Steinrauf Heidi,Lachin John M.,Canniff Jennifer,Greenbaum Carla,Herold Kevan C.,Skyler Jay S.,Weinberg Adriana

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study;Coiffier;Blood,1998

2. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998

3. Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group;Tobinai;Ann Oncol,1998

4. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma;Maloney;Blood,1994

5. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function;Pescovitz;N Engl J Med,2009

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Filamentous bacteriophages induce proinflammatory responses in intestinal epithelial cells;2024-06-24

2. Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathy;Clinical Kidney Journal;2024-06-21

3. Preclinical Pharmacokinetics and Pharmacology Study of RC98: A Programmed Cell Death Ligand 1 Monoclonal Antibody in Cynomolgus Monkeys;Current Pharmaceutical Design;2024-05

4. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes;Antibodies;2024-04-01

5. New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells;Nature Reviews Immunology;2024-02-08